throbber
0001
`
`PSG2026
`Catalent Pharma Solutions v. Patheon Softgels
`IPR2018-00422
`
`

`

`MERCK & CO., INC.
`Whitehouse Station, NJ.
`U.S.A.
`
`Ist Edition—1889
`2nd Edition—1896
`3rd Edition—1907
`4th Edition—1930
`5th Edition—1940
`6th Edition—1952
`7th Edition—1960
`8th Edition—1968
`9th Edition—1976
`10th Edition—1983
`11th Edition—1989
`
`Library of Congress Catalog
`Card Number 89-60001
`ISBN Number 0911910-12-3
`
`First Printing—March 1996
`Second Printing—April 1997
`
`Copyright © 1996 by MERCK & CO., INC.
`All rights reserved. Copyright under the Universal Copyright Convention
`and the International: Copyright Convention.
`Copyright reserved under the Pan-American Copyright Convention.
`Printed in the U.S.A.
`
`0002
`
`0002
`
`

`

`A.S.T.M.
`
`as-, aSyYM-
`at.
`ATCC
`atm, atmos
`at. no.
`ATP
`ATPase
`at. wt.
`BAN
`B cell
`
`BCG
`Bé
`Beilstein
`
`Belg. pat.
`Ber.
`
`BGG
`biol
`B.ILOS.
`
`
`
`Abbreviations and Selected Definitions
`Please consult the Glossary (Misc. Tables Section)for additional definitions.
`adenine; adenosine; absorbance .
`American Society for Testing
`(extinction)
`Materials
`Angstrom units
`asymmetrical, unsymmetrical
`Q,-antitrypsin
`atomic
`antibody -
`American Type Culture Collection
`absolute; absorption
`atmosphere(s), atmospheric
`absolute configuration
`atomic number
`abstract
`adenosine triphosphate
`c-aminobutyric acid
`adenosine triphosphatase
`acetyl CH;CO—
`atomic weight
`according
`British Approved Name
`angiotensin converting enzyme
`bone marrow or bursa of Fabricius
`acetyl coenzyme A
`derived cell
`acetic anhydride
`Bacillus Calmette-Guerin
`ethyl acetate
`Baumé(a specific gravity scale)
`acetic acid
`Beilstein’s Handbuch der
`acyl carrier protein
`Organischen Chemie
`American Chemical Society
`Belgian patent
`adrenocorticotropic hormone
`Chemische Berichte (Berichte der
`acyl coenzyme A
`Deutschen Chemischen
`antibody-dependent cellular
`Gesellschaft)
`cytotoxicity
`bovine gammaglobulin
`adding, addition
`biological
`adenine
`British Intelligence Objectives
`alcohol dehydrogenase
`Subcommittee
`adenosine diphosphate
`tert-butoxycarbonyl
`(United States) Atomic Energy
`biochemical oxygen demand
`Commission
`boiling
`antigen, silver
`basepair; boiling point; boils at;
`anaphylotoxin inhibitor
`boiling at Example: bp7 48°
`acquired immunodeficiency
`means boils at 48°C if the pressure
`syndrome
`is 70 mm Hi:
`alanine
`British Pharmacopeia
`alcohol(ic); ethanol: ethyl alcohol
`British Pharmaceutical Codex
`anti-lymphocyte globulin
`British patent
`alkali(ne)
`biological response modifier
`specific optical rotation at 25° C for
`bovine seram albumin
`D (sodium) line; absence of
`British thermal units
`brackets indicates optical rotation
`butyl
`of a liquid in a 1 decimeter cell,
`neat
`benzoyl C-H;CO—
`benzaldehyde
`anti-lymphocyte serum, amyotrophic
`benzoic acid
`lateral sclerosis
`concentration by volume(g/1 00m!)
`molar absorptivity (concn in
`after optical rotations only
`g-moles/l)
`cytosine; cytidine; complement
`amorphous
`Centigrade degrees: Celsius
`adenosine 5 ‘monophosphate
`degrees
`(adenylic acid)
`heat capacity (constant pressure)
`cyclic AMP
`(circa) about
`ampules
`Chemical Abstracts
`amount(s)
`calorie(s)
`anti-nuclear factor; atrial natriuretic
`calculate, calculated
`factor
`Canadian patent
`anhydrous
`carbobenzoxy
`stereodescriptor, see Glossary
`complete blood count
`Justus Liebig’s Annalen der Chemie
`cubic centimeter(s) (milliliter)
`American Pharmaceutical
`cholecystokinin
`Association
`circular dichroism
`approximate(ly)
`cytidine diphosphate
`alum precipitated toxoid
`carcinoembryonic antigen
`aqueous
`(confer) compare
`aryl
`complete Freund’s adjuvant (same as
`analytical reagent
`FCA)
`AIDSrelated complex
`complement fixation test
`Naunyn Schmiedebergs Archivfiir
`Experimentelle Pathologie und
`coronary heart disease
`congestive heart failure
`Pharmakologie
`chemical
`aromatic acyl radical
`Journal of the Chemical Society,
`arginine
`Chemical Communications.
`B-carboxyaspartic acid
`curie
`asparagine
`Colour Index (British)
`aspartic acid
`stereodescriptor, see Glossary
`association; associated
`centimeter(s)
`
`BOC
`B.O.D.
`boil.
`bp
`
`BP.
`B.PLC.
`Brit. pat.
`BRM
`
`CFT
`CHD
`CHF
`chem
`Chem. Commun.
`
`Ci
`CL
`cis-
`cm
`
`Xili
`
`0003
`
`A A A
`
`AT
`Ab
`abs
`abs config
`abstr
`Abu
`Ac
`acc
`ACE
`Acetyl CoA
`AO
`AcOEt
`AcOH
`ACP
`ACS,
`ACTH
`AcylSCoA
`ADCC
`
`add(n)
`Ade
`ADH
`ADP
`AEC
`
`Ag
`AI
`AIDS
`
`Ala
`alc, alcoh
`ALG
`alk
`[ole
`
`ALS
`
`any
`
`amorph
`AMP
`
`cAMP
`amps
`amt(s
`ANF
`
`anhydr
`anti
`Ann.
`APhA
`
`approx
`APT
`aq
`Ar
`AR.
`ARC
`Archiv Exp.
`Pathol.
`Pharmakol.
`
`Arg
`Asa
`Asn
`Asp
`assoc(d)
`
`0003
`
`

`

`(Deutsches Reichs-Patent)-German
`patent
`double stranded
`dithiothreitol
`dynes
`entgegen, stereodescriptor, see
`Glossary
`the absorbance of a solution
`containing one gram per 100 ml
`contained in a cell having an
`absorption path of one cm
`molar extinction coefficient (concn in
`g-moles/l)
`excitatory amino acid
`erythrocyte coated by antibody and
`complement
`experimental allergic
`encephalomyelitis
`electron capture
`eosinophil chemotactic factor of
`anaphylaxis
`electrocardiogram
`Enzyme Commission Number
`edition
`effective dose
`editor(s)
`ethylenediaminetetraacetic acid
`electroencephalogram
`{exempli gratia) for example
`epidermal growth factor
`the same (authors), plural of idem
`European Inventory of Existing
`Chemical Substances
`electrocardiogram
`enzyme-linked immunosorbent assay
`electromotive force
`ethylenediamine (in formulas)
`stereochemical descriptor, see
`Glossary
`Environmental Protection Agency
`erythropoietin; European Patent
`Office
`molar extinction coefficient (concn in
`g-moles/)); dielectric constant
`equation
`equilibrium
`equivalent
`especially
`electrostatic units of electrical charge
`ethyl C.H;—
`Viscosity
`(et alii) and others
`ef cetera
`ether
`ethyl alcohol
`European patent application
`electron volt
`evacuated
`evaporation
`stereochemical descriptor, see
`Glossary
`experimental(ly)
`extract, extracted
`externally
`Pabrenheit degrees: also Fourneau
`fructose 1-phosphate
`fructose 6-phosphate
`fatty acid
`fast atom bombardment
`flavin adenine dinucleotide (reduced
`form)
`Freund’s complete adjuvant (same as
`CFA)
`ferredoxin
`Food and Drug Administration
`CUS.A.)
`.
`Food, Drug and Cosmetic (U.S.A).
`
`D.R.P.
`
`ds
`DIT
`dyn
`(£)-
`1%
`Elan
`
`Ev
`
`EAA
`EAC
`
`eidem
`EINECS
`
`EKG
`ELISA
`emf
`en
`endo-
`
`EPA
`EPO
`
`(epsilon)
`
`eq
`equilib
`equiv
`esp
`esu
`Et
`1 (eta)
`et al.
`etc.
`Eto
`BtOH
`Hur. pat. Appi.
`ev
`evac
`evapn
`exo-
`
`O-(carboxymethy]) cellulose
`cell-mediated immunity
`cell-mediated lymphocytotoxicity
`cytidine 5’-monophosphate (cytidylic
`acid)
`ceniral nervous system
`coenzyme A
`collective volume
`compound
`composition
`concanavalin A
`concentrated
`concentration
`configuration
`constituent
`continued
`containing
`coenzyme Q (ubiquinone)
`corrected
`corresponding, corresponds
`centipoise
`chemically pure
`compound
`critical pressure
`critical temperature
`crystalline, crystals
`crystallization
`colony stimulating factor; cerebral
`spinal fluid
`Cosmetic, Toiletry and Fragrance
`Assoc.
`cytidine triphosphate
`cysteine
`cytosine
`density; specific gravity (d)° specific
`gravity at 19° referred to water at
`4
`dextro(rotatory), the opposite of /
`dextro (in configurational sense
`only), the opposite of L
`daltons
`O-(diethylaminoethyl)cellulose
`decompose(s), decomposition
`decomposition
`degree
`deliquescent
`indicates the locant of the double
`bond
`derivative
`determination
`diisopropyl fluorophosphate or
`diisopropy! phosphofluoridate
`dihydroalanine
`dehydrobutyrine,
`6-methyldehydroalanine
`difference
`dilute, diluted, dilution
`distillation
`racemic
`optically inactive by external
`compensation as contrasted with
`expt(ly)
`meso-
`exi(d)
`decimeter(s)
`exter
`dimethylacetamide
`disease modifying antirheumatic drug | °F
`dimethylformamide
`F-1-P
`dimethylsulfoxide
`F-6-P
`deoxyribonucleic acid
`FA
`complementary DNA
`| FAB
`mitochondrial DNA
`FAD (FADHL)
`deoxyribonuclease
`2,4-dinitro-1-fluorobenzene
`2,4-dinitrophenyl or 2,4-
`dinitrophenol
`dihydroxyphenylalanine
`degree of polymerization (number of
`monomeric units in the polymer)
`
`
`
`FCA
`
`Pd
`PDA.
`
`FD&C
`
`xiv
`
`0004
`
`CM-cellulose
`CMI
`CML
`CMP
`
`CNS
`CoA or CoASH
`coll. vol.
`compd.
`compn
`Con A
`conc(d)
`concn
`config
`constit
`contd
`contg
`CoQ
`cor(r)
`corresp
`P,
`epd
`crit press
`crit temp
`cryst
`crystn
`CSF
`
`cC
`
`CTFA
`
`CTP
`Cys
`
`Da
`DEAE cellulose
`dec, decomp
`decompn
`deg
`deliquesc
`A (delta)
`
`deriv
`determn
`DFP, DIFP, DIPF
`
`Dha
`Dhb
`
`diff
`dil(d}, (n)
`distin
`al-
`DL-
`
`DNFB
`
`0004
`
`€
`

`

`
`
`FDNB
`FDP
`if
`PFA
`EEC
`FIA
`
`FIAT
`
`FMN (FMNH))
`
`Fmoc
`Fortschr. Chem.
`Org. Naturst.
`
`fp
`FP
`FPLC
`Fr. pat.
`Fradl.
`
`GicA
`GicN
`GicNAc
`GICUA
`Gin
`Glu
`GluA
`Gly
`Glycerol-3-P
`Gmelin’s
`
`1-flnoro-2,4-dinitrobenzene
`fructose 1,6-diphosphate
`following
`tree fatty acid
`free from chlorine
`Freund’s incomplete adjuvant (same
`as ICFA)
`Field Information Agency, Technical
`(U.S. reports)
`flavin mononucleotide (reduced
`form); same as riboflavin
`phosphate
`9-tuorenylmethoxycarbonyl
`Fortschritte der Chemie Organischer
`Naturstoffe (Progress in the
`Chemistry of Organic Natural
`Products)
`freezing point
`flavoprotein
`fast protein liquid chromatography
`French patent
`P. Friedlander Fortschritte der Teer-
`Jarbenfabrikation, a collection of
`patents
`fructose
`follicle-stimulating hormone
`Fourier transform
`gram(s)
`guanine; guanosine
`glucose 1-phosphate
`glyceraldehyde 3-phosphate
`glucose 6-phosphate
`y-aminobutyric acid
`gallon(s)
`galactose
`N-acetyl-D-galactosamine
`microgram(s)
`gas chromatography
`glutamate dehydrogenase
`guanosine diphosphate
`geminal, stereodescriptor see
`Glossary
`geological
`German patent
`growth hormone
`gastrointestinal
`grams per liter
`y-carboxyglutamic acid
`glucose
`gas-liquid chromatography
`gluconic acid
`glucosamine
`N-acety]-b-glucosamine
`glucuronic acid
`glutamine
`glutamic acid
`glucuronic acid
`glycine
`glycerol 3-phosphate
`Gmelin’s Handbuch der
`Anorganischen Chemie, a
`comprehensive German
`encyclopedia of inorganic
`chemistry
`guanosine 5’~monophosphate
`(guanylic acid)
`cyclic GMP
`granulocyte macrophage colony
`stimulating factor
`government
`glycoprotein
`growth hormonereleasing factor
`glutathione (reduced)
`glutathione (oxidized)
`guanosine triphosphate
`genitourinary
`guanine
`
`XV
`
`GVH
`habit.
`Har
`Hb
`HbCO
`
`HbO.
`HCG
`Hey
`HDL
`HeLa
`
`HGG
`HGH
`His
`HIV
`Hiv
`HLA
`HMG-CoA
`
`Houben
`
`Houben Weyl
`
`TARC
`
`IARC Monographs
`
`ibid.
`LCC,
`ICPA
`
`ICSH
`
`IDDM
`idem
`
`incl
`incompat
`INN
`
`graft-versus-host
`habitat
`homoarginine
`hemoglobin
`carbon monoxide hemoglobin;
`carboxyhemogiobin
`oxyhemogiobin
`human chorionic gonadotropin
`homocysteine
`high density lipoproteins
`cells of the first continuously
`cultured (human cervical)
`carcinoma strain
`buman gamma globulin
`human growth hormone
`histidine
`human immunodeficiency virus
`o-hydroxyisovaline
`human leukocyte antigen
`3-hydroxy-3-methylelutaryl
`coenzyme A
`a German collection of medicinal
`patents
`Houben-Weyl Methoden der
`Organischen Chemie, a German
`collection of preparative methods
`in organic chemistry
`high performance (pressure, power)
`liquid chromatography
`hour
`human serum albumin
`homoserine
`herpes simplex virus
`hydroxytryptamine (serotonin)
`human T lymphotropic virus see also
`HIV
`hydroxylysine
`hydroxyproline
`optically inactive by internal
`compensation as i-inositol!: archaic
`for meso-
`inosine
`L-region antigen
`International Association of Cancer
`Registries
`international Agency for Research on
`Cancer
`IARC Monographs on the Evaluation
`of Carcinogenic Risk of Chemicals
`to Man
`Gbidem)at the same place
`Interstate Commerce Commission
`incomplete Freund’s adjuvant (same
`as
`interstitial cell-stimulating hormone
`(same as LH)
`insulin dependent diabetes mellitis
`the same (author); plural: eidem, the
`same (authors)
`inosine diphosphate
`(id est) that is
`Isoelectric focusing
`interferon
`intragastric
`immunoglobulin
`Interessengemeinschaft der
`Farbenindustrie, Aktiengesellschaft-
`the German dye trust
`insulin-like growth factor 1
`interleukin
`isoleucine
`intramuscular
`inosine 5’-monophosphate (inosinic
`acid)
`including
`incompatibility
`International Nonproprietary Name
`
`0005
`
`

`

`microgram
`millicurie
`
`molecular rotation
`
`[alp < mol wt
`100
`
`malate Cpeenase
`methyl CH,—
`acetone
`methyl alcohol
`Mellor’s Comprehensive Treatise on
`Inorganic and Theoretical
`Chemis
`milli-equivalent (0.001 of an
`equivalent)
`methionine
`N-formylmethionine
`methemoglobin
`millielectron volts
`manufacturing
`manufacture
`milligram
`major histocompatibility complex
`miicrocurie
`microgram
`microcrystalline
`migration inhibition factor
`minimum; minute(s)
`Mullerian inhibiting substance
`miscible
`mixture
`milliliter (cubic centimeter)
`minimum lethal dose
`mixed lymphocyte reaction
`millimeter
`millimicron(s), nm
`molecular weight
`Monatshefte fiir Chemie
`milliosmolar
`melting point; melts, melting at,
`when followed by a figure
`denoting temperature
`relative molecular mass
`magnetic resonance imaging
`meso- (internally compensated)
`mass spectrometry
`melanocyte-stimulating hormone
`(melanotropin)
`index of refraction (n79 for 20° and
`sodium light); normal, as n-propyl
`normal (equivalents per liter, as
`applied to concentration); nitrogen
`(as in N-methylpyridine)
`N-acetylneuraminic acid
`nicotinamide adenine dinucleotide
`(reduced form)
`nicotinamide adenine dinucleotide
`phosphate (reduced form)
`nonaspirin nonsteroidal anti-
`inflammatory drugs
`National Bureau of Standards
`National Collection of Type Cultures
`nucleoside 5’-phosphate
`Netherlands patent application
`National Formulary
`nanogram (107? grams)
`nerve growth factor
`Non-insulin dependent diabetes
`mellitis
`National Institute for Occupational
`Safety and Health
`nanometer
`nicotinamide mononucleotide
`(reduced form)
`nucleoside 5'’-monophosphate
`nuclear magnetic resonance
`New and Nonofficial Drugs
`(Lippincott, 1959-1964)
`
`mcg
`mCi
`
`MD
`
`MDH
`Me
`Me,CO—
`MeOH
`Mellor’s
`
`mEq
`
`Met
`fMet
`MetHb
`meV
`mfg, manuf
`mfr
`mg
`MHC
`mCi
`mg
`miucrocryst
`MIF
`min
`
`MS
`MSH
`
`n N
`
`NAcneu
`NAD* (NADH)
`
`NADP* (NADPH)
`
`NANSAIDS
`
`NBS
`NCTC
`NDP
`Neth. pat. Appl.
`NF.
`ng
`NGF
`NIDDM
`
`NIOSH
`
`nm
`NMN~ (NMN#)
`
`inorganic
`insoluble
`internal
`International
`intraperitoneal
`infrared
`immune response genes
`Internal Organization for
`Standardization
`isolation
`inosine triphosphate; idiopathic
`thrombocytopenic purpura
`international unit
`International Union of Chemistry
`International Union of Pure and
`Applied Chemistry
`.
`intravenous
`Japanese patent (unexamined)
`Japanese patent
`dissociation constant; equilibrium
`constant
`degrees Kelvin
`kilobase
`kilocalories(s)
`killer cell
`kilogram(s)
`a-ketoglutarate
`keyhole limpet hemocyanin
`kidney plasminogen activator
`liter
`levo(rotatory), the opposite of d
`levo (in configurational sense only),
`the opposite of D
`lactose
`lymphocyte-activating determinant
`wavelength
`laser microprobe mass analysis
`long acting thyroid stimulator
`pound(s)
`lethal concentration; liquid
`chromatography
`median lethal concentration, the
`concn of a chemical thatis
`estimated to be fatal to 50% of the
`organisms tested
`lymphocyte choriomeningitis
`lethal dose
`median lethal dose, the quantity of a
`chemical that is estimated to be
`fatal to 50% of the organisms
`tested
`lactate dehydrogenase
`low density lipoproteins
`leucine
`luteinizing hormone (same as ICSH)
`natural logarithm
`(loco citato) in the place cited
`logarithm (common)
`limit of impurities
`lipopolysaccharide
`lysine
`meter; given after mass number
`signifies metastable isomer
`meta chemical locant for ring
`substituents
`molar (concentration)
`monoclonal antibody
`maximum allowable concentration
`macrophage activating factor
`monoamine oxidase
`monoamine oxidase inhibitor
`mass spectrometry
`maximum, maxima
`myoglobin
`oxymyoglobin
`Manufacturing Chemists Association
`(U.S.A,)
`
`
`
`.
`Eva
`
`inorg
`insol
`intern
`Intl
`ip.
`IR
`Ir genes
`ISO
`
`isoln
`TIP
`
`LU.
`LU.C.
`LU
`
`Lv.
`Japan. Kokai
`Japan. pat.
`K
`
`AD
`(lambda)
`LAMMA
`LATS
`Ib
`LC
`
`LCso
`
`Mab, mAb
`MAC
`MAP
`MAO
`MAOI
`mass spec
`max
`Mb
`MbO,
`M.C.A.
`
`0006
`
`

`

`New and Nonofficial Remedies
`alkyl, univalent hydrocarbonradical
`(Lippincott, 1933-1958)
`(or hydrogen)
`nurober
`rectus (tight), stereodescriptor see
`chemical nomenclature descriptor,
`Glossary
`see Glossary
`radioallergosorbent test
`National Research Development
`red blood cell; red blood count
`Corporation
`aliphatic acyl radical
`nonsteroidal anti-inflammatory
`recrystallize, recrystallization
`gs
`reference
`National Service Center
`“roentgen equivalent physical’
`nucleoside 5’-triphosphate; National
`means a dose of ionizing radiation
`Toxicology Program (U.S.)
`capable of producing energy
`ortho chemical locant for ring
`absorption of 93 ergs per gram of
`substituents
`tissue
`denoting attachment to oxygen, as in
`respectively
`O- acetylhydroxylamine
`(in paper chromatography) ratio of
`ovalbumin
`movement of the band to the front
`oxaloacetate
`of the solvent
`RIA
`optical density
`radioimmunoassay
`Rib
`(opere citato) in the work cited
`D-ribose
`RIST
`organic
`radioimmunosorbenttest
`RNA
`Occupational Safety and Health Act
`ribonucleic acid
`hnRNA
`osmolar
`heterogeneous nuclear RNA
`mRNA
`ounce(s)
`messenger RNA
`concentration by weight (after optical|nRNA
`nuclear RNA
`rotations only)
`rRNA
`ribosomal RNA
`page(s)
`snRNA
`small nuclear RNA
`para chemical locantfor ring
`tRNA
`transfer (soluble) RNA
`substituents
`RNase
`ribonuclease
`inorganic phosphate
`RTECS
`Registry of Toxic Effects of Chemical
`pascal
`Substances
`p-aminobenzoic acid
`symmetrical
`platelet-activating factor
`denoting attachmentto sulfur as in
`polyacrylamide gel electrophoresis
`S-methyicysteine
`here and there, scattered
`sinister (left), stereodescriptor see
`patent
`Glossary
`Publication Board Report (United
`Society of Automotive Engineers
`States Department of Commerce,
`S-adenosylmethionine
`Scientific and Industrial Reports)
`saponification
`passive cutaneous anaphylaxis
`sarcosine
`Patent Co-operation Treaty
`saturated
`phosphoenolpyruvate
`subcutaneous
`positron emission tomography
`sodium dodecyl sulfate
`petroleum
`second(s)
`plaque-formingcell
`secondary
`3-phosphoglycerate
`separation
`prostaglandin
`serine
`pteroylglutamic acid (folic acid)
`International System of Units
`3-phosphoglyceroy! phosphate
`systemic lupus erythematosus
`acid-base scale; log of reciprocal of
`serotonin-noradrenaline reuptake
`hydrogen ion concentration
`inhibitor
`phytohemagglutin
`soluble; solubility
`phenylalanine
`solidifies, solidification
`physiological
`solution
`log of the reciprocal of the
`species; specific
`dissociation constant, iAog K
`spectroscopy
`phenylketonuria
`single photon emission computed
`polymorphonuclear leukocyte
`tomography
`inorganic pyrophosphate
`specific gravity
`parts per million
`species (plural)
`precipitate, precipitating
`square
`precipitated
`(sequentia) and following
`plastoquinone
`sheep red blood cells
`propyl (normal)
`slow reacting substance of
`prepared
`anaphylaxis
`preparation
`single stranded
`pressure
`subacute sclerosing panencephalitis
`proline
`selective serotonin reuptake inhibitor
`5-phosphoribosyl 1-pyrophosphate
`standard temperature and pressure
`pseudo
`sublimes
`point
`supplement
`parathyroid hormone
`symmetrical
`coenzyme Q (ubiquinone)
`stereochemical descriptor see
`(quae vide) whichsee, plural
`Glossary
`(quod vide) which see
`thymine; thymidine
`““roentgen’’ unit of radiation
`half-life
`racemic
`tablet(s)
`
`R
`
`(R)-
`
`RAST
`rbc
`RCO-
`reeryst(n)
`re
`rep [REP]
`
`resp
`R; or Re
`
`S-
`S
`
`(S)-
`
`S.A.E.
`SAM
`sapon(if)
`Sar
`satd
`i S.C.
`SDS
`sec
`SEC-
`sepn
`Ser
`SI
`SLE
`SNRI
`
`
`
`NNR.
`
`no.
`nor-
`
`NRDC
`
`NSAID(s)
`
`NsC
`NTP
`
`O-
`
`PAGE
`passim
`pat.
`PB report
`
`PCA
`PCT
`PEP
`PET
`petr, petrol
`PFC
`3PG
`PG
`PGA
`PGP
`pH
`
`PHA
`Phe
`physiol
`pK
`
`PKU
`PMN
`PPj
`ppm
`
`pee)
`PQ
`
`Pr
`Prepd
`Prepn
`press.
`Pry
`
`sol; soly
`solidif
`soln
`sp.
`spec
`SPECT
`
`sp gr
`Spp.
`sq
`Sqq
`SRBC
`SRS-A
`
`SS
`SSPE
`SSRI
`S.T.P.
`subl
`suppl
`sym-
`syn-
`T
`tie
`tabl
`
`xvii
`
`0007
`
`0007
`
`

`

`tuberculosis
`trichloroacetic acid; tricarboxylic
`acid
`thymus derivedcell
`thoracic duct lymphocyte
`thymidine diphosphate
`O-(triethylaminoethyl)-cellulose
`technical
`temperature
`tertiary
`thyrotropic hormone
`tetrahydrofuran
`tetrahydrofolic acid
`threonine
`thymine
`thin-layer chromatography
`thymidine 5’-monophosphate
`tobacco mosaic virus
`tumor necrosis factor
`trinitrophenyl
`tissue plasminogen activator
`thiamine pyrophosphate
`stereodescriptor see Glossary
`tris(hydroxymethylaminomethane;
`2-amino-2-hydroxymethylpropane-
`1,3-diol
`tryptophan
`thyroid-stimulating hormone
`tumor-specific transplantation
`antigens
`thymidine triphosphate
`tyrosine
`uracil or uridine
`uridine diphosphate
`uridine diphosphogalactose
`uridine disphosphoglucose
`United Kingdom
`uridine 5’-monophosphate (uridylic
`acid)
`uncorrected
`unsymmetrical, asymmetrical
`uracil
`United States Atomic Energy
`Commission
`United States Adopted Names
`
`
`
`
`
`U.S_D.
`ULS.D.A.
`
`USP.
`U.S.pat.
`UTP
`uv
`v
`v-
`Val
`var
`viz.
`VLDL
`vol
`vs
`viv
`
`wbe
`WHO
`wks
`wt
`wiv
`
`whw
`
`AMP
`yr(s)
`Z
`(Z)-
`
`Z. Physiol.
`
`~
`=
`>
`<
`
`United States Dispensatory
`United States Department of
`Agriculture
`United States Pharmacopeia
`United States patent
`uridine triphosphate
`ultraviolet
`volt(s)
`vicinal (adjacent)
`valine
`varie
`(videlicet) that is to say; namely
`very low density lipoproteins
`volume
`versus
`percent “‘volume in volume’’
`expresses the numberof milliliters
`of an active constituent in 100
`milliliters of solution
`white blood cell; white blood count
`World Health Organization
`weeks
`weight
`percent “‘weight in volume’’
`expresses the number of grams of
`an active constituent in 100
`milliliters of solution, and is used
`regardless of whether water or
`another liquid is the solvent
`percent “‘weight in weight”’
`expresses the number of grams of
`an active constituent in 100 grams
`of solution or mixture
`xanthosine monophosphate
`year(s)
`carbobenzoxy
`zusammen stereodescriptor see
`Glossary
`Hoppe-Seyler’s Zeitschriftfiir
`Physiologische Chemie
`approximately
`approximately equal
`greater than
`less than
`
`xvii
`
`TEAE cellulose
`tech
`temp
`tert-
`TH
`THF
`THFA
`Thr
`Thy
`TLC
`TMP
`TMV
`TNE
`TNP
`TPA
`TPP, Tapp
`trans-
`Tris
`
`Trp
`TSH
`TSTA
`
`TIP, dTTP
`Tyr
`
`UU
`
`DP
`UDP-gal
`UDP-gic
`ULK.
`UMP
`
`uncor(r)
`uUNS-, USYM-
`ra
`US.AEC.
`
`USAN
`
`0008
`
`

`

`
`>
`2386. Citrazinic Acid. 1,2-Dihydro-6-hydroxy-2
`
`pyridinecarboxylic acid; 2,6-dihydroxyisonicotinic acig. Ong.
`dihydroxy-4-pyridinecarboxylic acid. CgH,;NO,; mo,
`155.11. C 46.46%, H 3.25%, N 9.03%, O 41.26%,
`I
`cy.
`
`from citric acid with aq NH, at 140-160° under p,,.*8
`Bavley, Hamilton, U.S. pat. 2,729,647 (1956 to Pfizer) *U
`tification: Bavley et al, U.S. pat. 2,738,352 (1956 to Paia)
`N.
`OH
`oe
`HO.
`
`ao
`
`Wi
`
`|
`
`SS
`
`COOH
`
`Citramalic Acid
`
`"2384
`
`Separation of isomers: Naves, Bull. Soc. Chim.
`neral.
`France 1952, 521. Comprehensive reviews: J. L. Simonsen,
`The Terpenes, vol, I, 83-100 (1947); E. Guenther, The Essen-
`tial Oils, vol. II, 326-336 (1949); Gildemeister-Hoffmann,
`Die Aetherischen Oele, vol. 1V, 307-356 (4th ed., 1956).
`
`HO
`
`CH,
`
`|
`
`a
`
`|
`
`CH,
`
`H,C
`
`CHs
`
`H,C7
`
`~CHs
`
`Geranial(Citral a)
`
`Neral (Citral b)
`
`Geranial, light oily liquid. Strong lemon odor. bp,, 92-
`93°.
`dZ® 0.8888.
`n?#? 1.48982. Practically insol in water.
`Miscible with alc, ether, benzyl benzoate, diethyl phthalate,
`glycerol, propylene glycol, mineral oil, essential oils.
`Neral, light oily liquid. Lemon odor not as intense but
`sweeter than gerianal. bp,,¢ 91-92°. d} 0.8869. n2 1.48690,
`Solubilities same as gerianal.
`USE:
`In the synthesis of vitamin A, ionone and methyl-
`ionone. As a flavor, for fortifying lemon oil.
`In perfumery
`for its citrus effect in lemon and verbena scents, in cologne
`odors, in perfumes for colored soaps. Not stable to alkalies
`and strong acids. Will cause discoloration of white soaps
`and alkaline cosmetics.
`
`
`
`2384, Citramalic Acid. 2-Hydroxy-2-methylbutanedioic
`acid; 2-methylmalic acid; 2-hydroxy-2-methylsuccinic acid;
`a-hydroxypyrotartaric acid. C,;H,O,;; mol wt 148.12. C
`40.55%, H 5.44%, O 54.01%. Enzymatic synthesis: Barker,
`Blair, Biochem. Prepns. 9, 21 (1962). Chemical synthesis:
`Barker, ibid. 25; J. B. Wilkes, R. G. Wall, J. Org. Chem. 45,
`247 (1980). Stereoselective synthesis: E. G. J. Staring et al,
`Rec. Trav. Chim. 105, 374 (1986).
`HO CH,
`
`Yellowish powder with a greenish tinge; carbonizes ab. mee
`300° without melting. Ultrapure material which is White.if
`_ colorless, has been prepared. Almost insol in water; gj,
`sol in hot HCl; sol in alkali hydroxide or carbonate Sity,
`Alkaline solns turn blue on standing.
`MS.
`
`2387. Citric Acid.
`2-Hydroxy-1,2,3-propanetricarh,. :
`ylic acid; 8-hydroxytricarballylic acid. C,H,O,; Moly :
`192.13. C 37.51%, H 4.20%, O 58.29%. Widely distribu!
`in plants and in animal tissues and fluids. Produced fu
`mycological fermentation on an industrial scale using crud,
`sugar solns, such as molasses and strains of Aspergil};
`niger: See review by Von Loesecke, Chem. & Eng. News 45
`1952 (1945); Schweiger, U.S. pat. 2,970,084 (1961.to Mi
`Labs.); Faith, Keyes & Clark’s Industrial Chemicals, R”
`Lowenheim, M. K. Moran, Eds. (Wiley-Interscience, Ne
`
`York, 4th ed., 1975) pp 275-279. Also extracted from cits
`fruits (lemon juice contains 5 to 8%) and from pinea
`
`waste. Reviews: Wilson, Chem. & Met. Eng. 29, 787.(1923).
`
`Browne, Ind. Eng. Chem. 13, 81 (1921); Warneford, Hardy,
`ibid. 47, 1283 (1925); E. F. Bouchard, E. G. Merritt ig
`Kirk-Otbmer Encyclopedia of Chemical Technology yol:/6
`(Wiley-Interscience, New York, 3rd ed., 1979) pp 150-179.
`
`Toxicity: Gruber, Halbeisen, J. Pharmacol. Exp. Ther.. 9
`65 (1948).
`S
`
`
`
`
`
`
`
`
`
`COOH
`
`HO—C—COOH
`
`COOH
`
`HOOC
`
`COOH
`
`[a]? —23.4° (c = 3 in
`
`[o]#? +23.6° (¢ = 3 in
`
`dl-Form, deliquescent monoclinic prisms from ethyl ace-
`tate + petr ether, mp 117°. Sublimes. Freely sol in water,
`acetone. Sol in ethyl acetate, ether. Practically insol in petr
`ether, benzene.
`d-Form, crystals, mp 112.2-112.8°.
`H,0).
`i-Form, crystals, mp 112-113°.
`H,O)
`3-Hydroxy-8’-apo-8,/-carotenal;
`2385, £$-Citraurin.
`citraurin. C3g3HyO, mol wt 432.65. C 83.29%, H 9.32%, O
`7.40%. Carotenoid pigment found only in orange peel.
`Isoln by chromatography: Zechmeister, Tuzson, Ber. 69,
`1878 (1936); 70, 1966 (1937). The peels from 100 kilos of
`oranges yield about 35 mg. Structure: Zechmeister, Tuz-
`son,
`loc. cit.; Karrer, Solmssen, Helv. Chim. Acta 20, 682
`(1937); Karrer et al.,
`ibid. 1020; Zechmeister, v. Cholnoky,
`Ann. 530, 291 (1937); Karrer et al, Helv. Chim. Acta 21, 445
`(1938). Abs config: Bartlett et al, J. Chem. Soc. (C) 1969,
`2527. Synthesis: H. Pfander et al, Helv. Chim. Acta 63,
`1377 (1980).
`
`
`
`Thin orange or yellow-colored plates from benzene + petr
`ether, mp 147°. Absorption max (benzene): 497, 467 nm.
`Freely sol in acetone, ethanol, ether, benzene, and carbon
`disulfide. Sparingly sol in petr ether.
`.
`
`|
`
`Anhydr form, mp 153°. Crystais are monoclinic. holo:
`hedra and crystallize from hot coned aq soln. d 1.665.-"At..
`25°, pK, 3.128 pK, 4.761; pK, 6.396, Bates, Pinching,.J.
`
`Am. Chem. Soc. 71, 1274 (1949). Soly in water: 54.0% w/w.
`
`at 10°; 59.2% at 20°; 64.3% at 30°; 68.6% at 40°; 70.9% at 50%.
`73.5% at 60°; 76.2% at 70°; 78.8% at 80°; 81.4% at 90°; 84.0%:
`at 100°.
`oes
`Monohydrate, orthorhombic crystals from cold aq solns.:
`Pleasant, sour taste. d 1.542. Monohydrate crystals lose
`water of crystn in dry air or when heated at about 40 to'50',.
`slightly deliquescent in moist air.
`Softens at 75°. MP.
`~100°. pH of 0.1N soln = 2.2. Densities of aqueous soll”
`(15°/159):
`10% = 1.0392; 20% = 1.0805; 30% = 1.1244
`40% = 1.1709; 50% = 1.2204; 60% = 1.2738. Soly.B
`g/100 g satd soln:
`ether 2.17; chloroform 0.007; amyl:
`alcohol 15.43; amyl acetate 5.98; ethyl acetate 5.28. Soly at.
`19° in g/100 g solvent: methanol 197; propanol 62.8: LDs..
`ip. in rats: 975 mg/kg (Gruber, Halbeisen).
`.
`Pharmaceutical Incompatibilities: Potassium tartrate; al-
`kali and alkaline earth carbonates and bicarbonates, 2¢¢
`tates, sulfides. Dilute aq solns may ferment on standing-
`Barium salt heptahydrate, C,,H,)Ba,0,,.7H,O, barium
`citrate. Powder. Loses all H,O at 150°. Sol in 1750 paris
`water; freely sol in dil HCl or HNOpractically insol 3°
`alcohol.
`oe
`Ethyl ester, C,,H,9O,, ethyl citrate, triethyl citrate. Bitte}
`oily lig. d?° 1.137.
`bpygq 294°; bp) 127°. Viscosity at 25:
`35.2 cps. Pour pt ~10°. 20 1.4455. Soly: water ~6.9%;
`peanut oil 0.8%. Misc with alc, ether.
`t
`USE: Acidulant in beverages, confectionery, effervesc®™
`salts, in pharmaceutical syrups, elixirs, in effervescent pOW*
`ders and tablets, to adjust the pH of foods and as synet
`
`Page 392
`
`Consult the Name Index before using this section.
`
`0009
`
`

`

`
`
`B-Citronellol
`
`2391
`
`HO.
`
`HO’
`
`HOOG
`
`oO
`
`fe)
`
`A
`(OL ee
`
`CH,
`
`Dibydrate, yellow crystals, effervescence at 155°, dec 290-
`300° (considerable antecedent blackening).
`Freely sol
`in
`ethanol; readily sol in aq sodium carbonate soln; sparingly
`sol in water, chloroform.
`Insol in benzene, hexane. Stable
`to acid and alkali at 100°.
`
`3,7-Dimethyl-6-octenal. C4)H,,0;
`2390. Citronellal.
`mol wt 154.25. C 77.87%, H 11.76%, O 10.37%. Chief
`constituent of citronella oil; also found in many other vola-
`tile oils, such as lemon, lemon grass, melissa: Tiemann, Ber.
`32, 834 (1899); Spoon, Chem. Weekbl. 54, 236 (1958).
`Structure: Naves, Bull. Soc. Chim. France 1951, 505;
`Eschinazi, J. Org. Chem. 26, 3072 (1961).
`CH,
`
`Hes,
`
`HC
`
`CHg
`
`“etic antioxidant, in processing cheese. Used in beverages,
`gist 5, jams, preserves and candy to provide tartness. In the
`jellies of alkyd resins; in esterified form as plasticizer, foam
`m ‘pitor.
`In the manufofcitric acid salts. As sequestering
`jolt
`to remove trace metals. As mordant to brighten
`agen 5; in electroplating; in special inks; in analytical chem-
`color for determining citrate-soluble P,O,; as reagent for
`isttY 4, mucin, glucose, bile pigments.
`aDAP caT: Component of anticoagulant citrate solns
`Gijrate dextrose soln; citrate phosphate dextrose soln; citric
`acid syTUP)-
`388. Citrinin.
`(3R-trans)-4,6-Dihydro-8-hydroxy-3,4,5-
`. ethyl-6-0x0-3H-2-benzopyran-7-carboxylic acid; Antimy-
`trim C4gH4Os. mol wt 250.25. C 62.39%, H 5.64%, O
`cin 7%. Antibiotic substance produced by a white spore
`31. sgillus which has been placed under the species name
`aseillus niveus (Thorn and Raper). Also produced in
`ASP!at quantities by Penicillium citrinum: Hetherington,
`smmtcick, Trans. Roy. Soc. London B220, 269 (1931); Rais-
`Rav smith, Chem. & Ind (London) 60, 828 (1941); Timo-
`tric ence 96, 494 (1942); Timonin, Rovatt, Can. J. Pub.
`ealth 35, 80 (1944).
`Identity with antimycin: Haese,
`eh Pharm. 296, 227 (1963). Structure: Brown et al, J.
`nem. Soc. 1949, 867; Warren et al, J. Am. Chem. Soc. 79,
`3812 (1957); Kovac et al, Nature 190, 1104 (1961). Synthe-
`is: Cartwright et al, J. Chem. Soc. 1949, 1563; J. A. Bar-
`per et al, J. Chem. Soc. Perkin Trans. I 1986, 2101. Stereo-
`chemistry: Cram, J. Am. Chem. Soc. 72, 1001 (1950); Meh-
`ta, Whalley, J. Chem. Soc. 1963, 3777; Mathieson, Whalley,
`ibid: 4964, 4640. Physical characteristics and toxicity:
`Nagai et al, Chem. Zentr. 1958, 8088, C.A. 55, 1914 (1961.
`‘Crystal and molecular structure: Rodig, Chem. Commun.
`4971, 1553. Biosynthesis:
`J. Barber et al, J. Chem. Soc.
`‘perkin Trans. I 1981, 2577; L. Colombo etal., ibid: 2594.
`Physicochemical data: A. E. Pohland et al, Pure Appl.
`“Chem. 54, 2219 (1982). Toxicology: A. M. Ambrose, F. De
`Eds, J. Pharmacol. Exp. Ther. 88, 173 (1946). Review: Saito
`“et al, “Yellowed Rice Toxins” in Microbial Toxins, A. Cieg-
`Jer, S. Kadis, A. Ajl, Eds. (Academic Press, New York,
`“4971 vol. VI, pp 357-367.
`
`:
`
`HOOC.
`

`
`OH
`
`Oo
`
`™y9
`
`“CH
`
`CH,
`
`CH,
`
`
`
`d 0.848-
`[ol +11.50°.
`n® 1.4460.
`bp, 47.
`Liquid.
`0.856. Soluble in alcohols; very slightly sol in water.
`a-citronellal, 3,7-Dimethyl-7-octenal, rhodinal. Liquid.
`bp,, 51°.
`12? 1.4410.
`[a]? +9.75°.
`UsE:
`In soap perfumes; insect repellent.
`2391, $-Citronellol. 3,7-Dimethyl-6-octen-1-ol; 2,6-di-
`methyl-2-octen-8-ol; citronellol; cephrol. C,gH0; mol wt
`156.27. C 76.86%, H 12.90%, O 10.24%.
`I-Form is a con-
`stituent of rose and geranium oils. d-Form occurs in Ceylon
`and Java citronella oils. History:
`J. L. Simonsen, L. N.
`Owen, The Terpenes vol. I (University Press, Cambridge,
`2nd ed, 1947). Prepn of (+)-form: Adams, Garvey, J. Am.
`Chem. Soc. 48, 477 (1926); Ofner et al, Helv. Chim. Acta 42,
`2577 (1959). Prepn of (+)-form: Rienicker, Ohloff, Angew.
`Chem. 73, 240 (1961); Naves, Tullen, Hely. Chim. Acta 44,
`1867 (1961); Eschinazi, J. Org. Chem. 26, 3072 (1961); Rie-
`nicker, Chimia 27, 97 (1973); C. G. Overberger, J. L. Weise,
`J. Am. Chem. Soc. 90, 3525 (1968); T. Sato et al, Tetrahe-
`dron Letters 1980, 3377. Prepn-of (—)-form: Ohloff,
`loc.
`cit.; Rienacker,
`loc. cit.; Shono et al, Tetrahedron Letters
`1974, 1295; K. Mori, T. Sugai, Synthesis 1982, 752. Syn-
`thesis of (+) or (—)-form from isoprene: Hidai et al, Chem.
`Commun. 1975, 170. Stereospecific prepn via microbiologi-
`cal (Saccharomyces cerevisiae) reduction: P. Gramatica et
`al., Experientia 38, 775 (1982). Manuf: Worochet al; Bain;
`Webb, U.S. pats, 2,990,422; 3,005,845; 3,028,431 (1961,
`1961, 1962, all to Glidden); Eschinasi, U.S. pat. 3,052,730
`(1962 to Givaudan). Abs config of the (+)-form: Freuden-
`berg, Hohmann, Ann. 584, 54 (1953); Freudenberg, Lwow-
`ski, ibid. 587, 213 (1954). NMR, HPLC determn of R/S
`Gone ratios: D. Valentine et al, J. Org. Chem. 41, 62
`1976).
`HCH,
`
`
`
`fal}
`Lemon-yellow needles from alcohol, dec 175°.
`—37.4(c = 1.15 in alc.). uv max: 250, 331 nm (E}%, 370,
`418). Strong acid. Practically insol in water. Sol in alco-
`hol, dioxane, dilute alkali. Solns change color with changes
`im pH, from lemon-yellow at pH 4.6 to cherry-red. at pH
`2.9. Poisonous! LDgy in mice, rats (mg/kg):
`35, 67 ip.
`(Ambrose, De Eds).
`Methyl citrinin, C,,H,,O5, plates from benzene, d

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket